Antiviral Activity of Ergoferon against Group A Rotavirus
- 作者: Emelianova A.G.1, Shilovskii I.P.2, Sundukova M.S.2, Khaitov M.R.2, Epshtein O.I.1
- 
							隶属关系: 
							- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
- State Research Center Institute of Immunology, Federal Medical-Biological Agency
 
- 期: 卷 161, 编号 6 (2016)
- 页面: 806-807
- 栏目: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/237801
- DOI: https://doi.org/10.1007/s10517-016-3516-x
- ID: 237801
如何引用文章
详细
Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.
作者简介
A. Emelianova
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
							编辑信件的主要联系方式.
							Email: agemelianova@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
I. Shilovskii
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
M. Sundukova
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
M. Khaitov
State Research Center Institute of Immunology, Federal Medical-Biological Agency
														Email: agemelianova@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
O. Epshtein
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
														Email: agemelianova@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					